Quick Take
Oscar Health (OSCR) (OSCAR) has filed to raise $100 million in an IPO of its Class A common stock, according to an S-1 registration statement.
The firm provides a technology-driven healthcare insurance platform in the United States.
OSCAR has produced contracting topline revenue and high operating losses in 2020.
I’ll provide a final opinion when we learn more about the IPO from management.
Company & Technology
New York, New York-based Oscar was founded to develop a modern healthcare insurance delivery system directly for individual consumers and through businesses in the U.S.
Management is headed by co-founder and CEO Mario Schlosser, who was previously co-founder of Vostu, a social gaming company in Latin America and senior investment associate at Bridgewater Associates, 'where he developed analytical trading models.'
Below is a brief overview video of a sample 'Conversation with Oscar':
Source: Oscar Health
Oscar has received at least $1.74 billion from investors including Alphabet (GOOG) (GOOGL), Fidelity Management Research, Formation8, General Catalyst, Khosla Ventures and Thrive Capital.
Patient Acquisition
The firm seeks consumer policy holders in 18 U.S. states and counts more than 529,000 plan members as of December 31, 2020.
In addition, the company also provides virtual care offerings, such as its Virtual Primary Care service, which has grown in usage since the onset of the COVID-19 pandemic.
General & Administrative expenses as a percentage of total revenue have risen as revenues have decreased, as the figures below indicate:
G&A | Expenses vs. Revenue |
Period | Percentage |
2020 | 36.0% |
2019 | 22.7% |
Source: Company registration statement
The General & Administrative efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of General & Administrative spend, was negative (0.2x).
Market & Competition
According to a 2020 market research report by Grand View Research, the
Gain Insight and actionable information on U.S. IPOs with IPO Edge research.
Members of IPO Edge get the latest IPO research, news, and industry analysis.
Get started with a free trial!